Status:
COMPLETED
Special Drug Use Investigation for LAMICTAL Bipolar
Lead Sponsor:
GlaxoSmithKline
Conditions:
Bipolar Disorder
Eligibility:
All Genders
Brief Summary
This post-marketing surveillance study is designed to collect and assess information on safety and effectiveness of lamotrigine tablets in patients with bipolar disorder in routine clinical practice. ...
Eligibility Criteria
Inclusion
- Patients with bipolar disorder
- Patients treated with lamotrigine tablets for the first time
Exclusion
- Not applicable
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
1036 Patients enrolled
Trial Details
Trial ID
NCT01428518
Start Date
November 1 2011
End Date
January 1 2016
Last Update
April 25 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.